LeafNLP Demos
Back to explore

Report #2878611

Received Dec 18, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
ID
Recovered
Unknown
Vaccinated
Nov 10, 2025
Onset
Nov 10, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1946909IM

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

13 Year Old Patient Received A Dose of Heplisav-B; Initial report received on 01-Dec-2025. A nurse reported that a 13-year-old female received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 10-Nov-2025, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot number 946909, expiration date 26-Jan-2025, and NDC number 43528-003-05; site not provided)] intramuscularly. The patient was 13 years old at the time. No adverse effects reported. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.